Search for: "AstraZeneca, AB" Results 1 - 20 of 92
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jan 2023, 10:19 am by Annsley Merelle Ward
Moreover, not only Oxford but possibly third parties (such as other investors in ONI who may have an interest in ensuring that the Licence remains in place to ensure that ONI is not exposed to potential infringement claims) may wish to contend that it would be wrong for the English court to risk undermining ONI's business by voiding its key Licence ab initio. [read post]
4 Jan 2022, 6:00 am by Douglas J. Bucklin, Ph.D.
Cir. 2021) 2021-1729 AstraZeneca AB and AstracZeneca Pharmacueticals LP (AstraZeneca) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
9 Dec 2021, 7:15 am by Logan Murr
The decision relates to AstraZeneca AB’s and AstraZeneca Pharmaceuticals LP’s (collectively “AstraZeneca”) lawsuit against Mylan and Kindeva Drug Delivery LP (collectively “Mylan”) for infringing all claims of U.S. [read post]
8 Dec 2021, 8:52 am by Lawrence B. Ebert
The outcome AstraZeneca AB and AstraZeneca Pharmaceuticals LP (collectively, “AstraZeneca”) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
8 Dec 2021, 8:47 am by Dennis Crouch
by Dennis Crouch Astrazeneca AB v. [read post]
5 Aug 2021, 12:12 pm by Lawrence B. Ebert
The outcome was a vacating of the district court's grant of JMOL and a lot of discussion of drug "skinny labels": GlaxoSmithKline LLC and SmithKline Beecham (Cork) Ltd. [read post]
5 Feb 2021, 5:30 am by Ralf Michaels
The first difficulty is thus to identify the parties to the APA.[8] According the APA, the parties are AstraZeneca AB and the European Commission “acting on behalf and in the name of the member states of the European Union”. [read post]
23 Aug 2019, 6:23 am by John Jascob
For an example of a bad interpretation of a complex contract that might have come out the right way with a little help of signals in the contract, take a look at Astex Therapeutics Limited and AstraZeneca AB, [2018] EWCA Civ. 2444, Case No. [read post]
29 Jun 2018, 12:21 pm by Lawrence B. Ebert
(“Impax”), AstraZeneca AB, and AstraZeneca UKLimited (together, “AstraZeneca”), and entering an injunctionagainst Lannett pursuant to 35 U.S.C. [read post]
10 Jan 2018, 6:36 pm by Lawrence B. Ebert
AstraZeneca AB v.Apotex Corp., 782 F.3d 1324, 1334 (Fed. [read post]
7 Sep 2017, 9:59 pm by Patent Docs
AstraZeneca AB affirming the patentability of all challenged claims. [read post]
12 May 2017, 9:05 am by Tom Lamb
., AstraZeneca Pharmaceuticals LP, AstraZeneca LP, AstraZeneca PLC, and AstraZeneca AB (collectively, Bristol-Myers/AstraZeneca), which developed, manufactured, and marketed the drugs, failed to adequately test the drugs and warn of their risks. [read post]
3 May 2017, 9:59 pm by Patent Docs
InnoPharma Licensing, LLC v AstraZeneca AB PTAB Petition: IPR2017-00900; filed February 17, 2017. [read post]
6 Apr 2017, 9:59 pm by Patent Docs
AstraZeneca AB PTAB Petition: IPR2017-00631; filed January 9, 2017. [read post]